Last reviewed · How we verify
Placebo capsule of DLBS3233 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo capsule of DLBS3233 (Placebo capsule of DLBS3233) — Dexa Medica Group. This is a placebo capsule used as a control in clinical trials of DLBS3233.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo capsule of DLBS3233 TARGET | Placebo capsule of DLBS3233 | Dexa Medica Group | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo capsule of DLBS3233 CI watch — RSS
- Placebo capsule of DLBS3233 CI watch — Atom
- Placebo capsule of DLBS3233 CI watch — JSON
- Placebo capsule of DLBS3233 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo capsule of DLBS3233 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-capsule-of-dlbs3233. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab